2016 ADX
2016 ADX Banner

Leveraging Pharmacies for Rapid Diagnostics

According to a recent report by Accenture, nearly 3,000 retail health clinics are expected by 2017. Meanwhile, 95% of the nation’s 60,000 pharmacies are providing immunizations, a number that has grown despite initial hesitation. Consumers are beginning to see their local pharmacy, a place traditionally reserved for medications and greeting cards, as a stop for acute care and chronic disease management. Currently, about 18% of pharmacies hold a CLIA waiver allowing them to perform diagnostic and screening tests. Given the convenient locations and hours as well as the trust consumers already have in their pharmacists, there remains huge opportunity for growth. Cambridge Healthtech Institute’s Second Annual Leveraging Pharmacies for Rapid Diagnostics will showcase outcomes data and practice models, an overview of the diagnostics landscape, and bring in the payor perspective. Legal considerations will be discussed from state-to-state practice laws to pharmacy-based CLIA waivers and Collaborative Practice Acts. Overall, this event will bring together representatives from both diagnostics and pharmacy to continue planning a path forward.

Day 1 | Day 2 | Short Courses | Download Brochure


WEDNESDAY, AUGUST 24

10:30 am Registration

12:50 pm Luncheon Presentation (Sponsorship Opportunity Available) or Enjoy Lunch on Your Own

1:25 Ice Cream and Cookie Break in the Exhibit Hall with Poster Viewing


POINT-OF-CARE PRACTICE MODELS AND IMPLEMENTATION

1:50 Chairperson’s Opening Remarks

Michael E. Klepser, Pharm.D., FCCP, Professor, Pharmacy Practice, Ferris State University College of Pharmacy

2:00 The Implementation of Rapid Diagnostic Assays in the Hospital Setting

Edina Avdic, Pharm.D., MBA, BCPS, AQ-ID, Clinical Specialist, Infectious Diseases; Associate Director, Antimicrobial Stewardship Program, Pharmacy, John Hopkins Medicine

Rapid diagnostic assays been repeatedly shown to reduce the time to identification of microorganisms and their resistance markers. When coupled with antimicrobial stewardship (AS) interventions, they can decrease the time to effective and/or optimal antimicrobial therapy as well as enhance de-escalation of unnecessary broad spectrum antibiotics. Antimicrobial stewardship teams are essential in rolling out new laboratory tests by providing education to clinicians on appropriate interpretation and guiding therapy modification in a timely manner. Hospital clinical pharmacists play a critical role in the interpreting these assays for clinicians and assisting AS teams with interventions.

2:30 Point-of-Care Diagnostics in a Retail Health Setting

Alexander Sbordone, Manager, Operations, MinuteClinic, CVS Health

As retail health continues to grow, clinics are looking to increase their service offerings. The expansion of services in clinics should include point-of-care (POC) diagnostics that will assist with the proper diagnoses and treatment of patients. This presentation will review current testing utilized at MinuteClinic, how expanded POC testing may allow for additional services in the retail setting, and the challenges that POC testing presents in this environment.

3:00 Successful Disease Management Programs

Michael E. Klepser, Pharm.D., FCCP, Professor, Pharmacy Practice, Ferris State University College of Pharmacy

3:30 Late Breaking Presentation 

Patrick O’Malley, Retail Pharmacy Integration, Doctor on Demand

Tania Elliott, M.D., Medical Director, Doctor on Demand

4:00 Refreshment Break in the Exhibit Hall with Poster Viewing

4:45 Clinical Application of Point-of-Care Testing in Disease State Management Services

Suzanne Higginbotham, Pharm.D., BCACP, Director, Center for Pharmacy Care; Director, Residency Programs, Duquesne University Mylan School of Pharmacy

This presentation will be an overview of point-of-care testing services in disease state and medication therapy management. The speaker will seek to demonstrate the use of point-of-care testing within an MTM model framework, provide clinical pearls on communication and collaboration with this model among other health care providers, and analyze the economic and clinical outcomes of providing this service to the community.

5:15 DISEASE MANAGEMENT COMPETITION: Treating Patients at the POC

DiseaseMgmtCompetitionThis year’s Pharmacy-Based Diagnostics event will play host to a Pharmacy Student Point-of-Care Disease Management Competition.

Our competition emulates the APhA Patient Counseling Competition and the ASHP Clinical Skills Competitions. The winning student will be awarded a plaque to designate the accomplishment and a stipend of $250.00. Additional details can be found at NextGenerationDX.com/Pharmacy-Diagnostics/Disease-Management


6:15 Close of Day

6:00 Dinner Short Course Registration


6:30- 8:30 pm RECOMMENDED DINNER SHORT COURSE*

SC13: Use of CLIA-Waived Point-of-Care and Rapid Diagnostic Tests in Community Pharmacies

*Separate registration required


Day 1 | Day 2 | Short Courses | Download Brochure


THURSDAY, AUGUST 25

7:30 am Problem-Solving Breakout Discussions with Continental Breakfast

Point of Care Testing Devices in Community Pharmacies

Moderator: Allison M. Dering-Anderson, BA, Pharm.D., RP, FAAIM, Clinical Assistant Professor, Pharmacy, University of Nebraska College of Pharmacy

  • Footprints are bigger than you think
  • Speed can kill the business model
  • What's left over? It matters!

Point-of-Care Diagnostics in a Retail Health Setting

Moderator: Alexander Sbordone, Manager, Operations, MinuteClinic, CVS Health

  • What products/tests work in this space
  • Collection issues. Challenges with obtaining a test sample
  • What is the ROI for offering tests in this space
  • Reimbursement challenges

 PRACTICE MODELS AND IMPLEMENTATION (CONT.)

8:25 Chairperson’s Remarks and Competition Winner Announcement

Donald G. Klepser, Ph.D., MBA, Associate Professor, Pharmacy Practice, University of Nebraska Medical Center

8:30 Successful and Best Practice Models for Precision Medicine and Pharmacogenetics in Community Pharmacy

Olivia Bentley, Pharm.D., Director, Clinical Services, Rx Clinic Pharmacy

Amina Abubakar, Pharm.D., Owner, Rx Clinic Pharmacy

Since President Obama's State of the Union address in support of Precision Medicine and pharmacogenetics (PGx), there are still many gaps in making this innovative technology a reality. Pharmacy Today featured Drs. Amina Abubakar and Olivia Bentley in the July 2016 issue for their innovative clinical services in community pharmacy with PGx. Learn from the lead pharmacists of the Pharmacogenetics Centers of Excellence about successful business models that incorporate best practices for the clinical application and implementation of pharmacogenetics in community pharmacy. They will share their journey, model of delivery, and how they came to speak of PGx to the FDA and the White House Office of Science and Technology Policy.

REIMBURSEMENT FOR PHARMACY-BASED TESTING

9:00 Engaging Third Party Payers - The Holy Grail of Pharmacy-Based POCT

Donald Klepser, Ph.D., MBA, Associate Professor, Pharmacy Practice, College of Pharmacy, University of Nebraska Medical Center

This talk will provide an overview of the current state of reimbursement of community pharmacy-based point-of-care testing. It will cover opportunities and barriers to enhancing third party reimbursement for POCT services.

9:30 Exploring Retail Consumer Perceptions of Point-of-Care Tests: A Conjoint Analysis Study

Kenneth C. Hohmeier, Pharm.D., Director, Community Affairs, Assistant Professor, Clinical Pharmacy, University of Tennessee Health Science Center

This brief, original research presentation will discuss results from a consumer preference market analysis study. The study’s aim was to describe and compare consumer preferences for various characteristics of point-of-care tests using a cross sectional questionnaire that was developed using principles of conjoint (trade-off) analysis. This well researched, popular methodology is used in marketing research internationally and allows the researcher to quantify consumer preferences on product features.

Celsee Diagnostics10:00 Coffee Break in the Exhibit Hall with Poster Viewing


THE DIAGNOSTICS LANDSCAPE

10:50 Can We Perform Diagnostic POC Tests for Sexually Transmitted Infections in a Pharmacy?

Charlotte_GaydosCharlotte A. Gaydos, MS, MPH, DrPH, Professor, Division of Infectious Diseases, Department of Medicine, Johns Hopkins University

Pharmacies are performing POC tests for influenza. Since POC/rapid tests are becoming available for sexually transmitted infections (STIs) such as chlamydia, gonorrhea, trichomonas, syphilis, and HIV, it may be possible to provide assays for patients who attend pharmacy clinics. Such assays can be performed on self-collected specimens such as urine, vaginal swabs, and finger-stick blood. Privacy and confidentiality are important to patients with STIs. It is time to investigate options.

11:20 Utilizing Point-of-Care Testing in a Pharmacy Setting

Ray_AhmedRay Ahmed, Marketing Manager, Sales and Marketing, OraSure Technologies, Inc.

Point-of-care testing is rapidly becoming a benchmark of testing in a variety of clinical settings. This is especially true in the pharmacy setting, where many retail and specialty pharmacies have increased their service offerings outside of the traditional filling of prescriptions for patients. While infectious disease rapid testing is a logical fit in this expanded service offering, there are also challenges with pharmacies implementing rapid testing programs.

11:50 CLIA Waiver: A Primer

Gail Radcliffe, President, Consulting, Radcliffe Consulting, Inc.

12:20 pm Sponsored Presentation (Opportunity Available)

12:50 Luncheon Presentation (Sponsorship Opportunity Available) or Enjoy Lunch on Your Own

1:20 Session Break


LEGAL CONSIDERATIONS

2:00 Chairperson’s Remarks

Alex J. Adams, Pharm.D., MPH, Executive Director, Idaho State Board of Pharmacy

2:05 Pharmacist Point-of-Care Testing: A State Law Framework

Alex_AdamsAlex J. Adams, Pharm.D., MPH, Executive Director, Idaho State Board of Pharmacy

Pharmacies must navigate a complex maze of federal and state laws in order to fully engage in point-of-care testing. This session will discuss federal CLIA laws, state-level restrictions on CLIA-waived testing, and Collaborative Practice Laws that enable pharmacists to act on the results of tests.

2:35 Legal Considerations in Point-of-Care Testing in Pharmacies

Ally_Dering-AndersonAllison M. Dering-Anderson, BA, Pharm.D., RP, FAAIM, Clinical Assistant Professor, Pharmacy, University of Nebraska College of Pharmacy

Pharmacists are well-versed in legal matters concerning drugs and dispensing. Adding Point-of-Care Testing services bring in additional regulations and legal considerations. This program will highlight several of the agencies involved in regulating point-of-care testing in community pharmacies.

3:05 PANEL DISCUSSION: PAYOR, PHARMACIST, DEVELOPER

Panelists: Ray Ahmed, Marketing Manager, Sales and Marketing, OraSure Technologies, Inc.

Michael E. Klepser, Pharm.D., FCCP, Professor, Pharmacy Practice, Ferris State University College of Pharmacy

Alexander Sbordone, Manager, Operations, MinuteClinic, CVS Health

  • What can pharmacists expect from tests?
  • Which tests fit best in pharmacy?
  • How are we getting paid?

4:05 Close of Conference



Day 1 | Day 2 | Short Courses | Download Brochure

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag  



2016 Brochure

2016 Next Generation Dx Summit Brochure


ADX 2016 CAG Brochure Icon
 

Premier Sponsors

MolecularMD

Positive ID

Precision for Medicine 

View All Sponsors

View Media Partners

Media Gallery Thumb

Related Products


IPR_IMX

IPR_MBO